168
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia

, ORCID Icon, , , , , , , , ORCID Icon & show all
Pages 3601-3615 | Received 07 Jun 2022, Accepted 17 Sep 2022, Published online: 21 Nov 2022

Figures & data

Table 1 Revisions to GDAQ

Table 2 Final Factor Loadings for Scales by Respondent Group

Figure 1 Principal component analysis results for total sample: Scree plot and variance explained for NG rating items.

Abbreviation: NG, nasal glucagon.
Figure 1 Principal component analysis results for total sample: Scree plot and variance explained for NG rating items.

Figure 2 Principal component analysis results for total sample: Scree plot and variance explained for AI rating items.

Abbreviation: AI, autoinjector glucagon.
Figure 2 Principal component analysis results for total sample: Scree plot and variance explained for AI rating items.

Table 3 Fit Metrics for Confirmatory Factor Analysis

Table 4 Descriptive Statistics for Device Rating Items Not Included in Factor Analyses by Respondent Group

Table 5 Cronbach’s Alpha for Final Scales by Respondent Group

Table 6 Correlations of Scales with Global Item by Respondent Group